Previous 10 | Next 10 |
Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that its CEO Matt Gline will present at Guggenheim’s Targeted Protein Degradation Day on Wednesday, March 16, 2022 at 1:15 p.m. ET. A live w...
Inflation is back. It’s back in a major way. The consumer price index for all items rose 0.6% in January, driving up annual inflation by 7.5%. That marked the biggest gain since February 1982 and was even higher than the Wall Street estimate. (3) It’s taking its toll on everyone...
Conference call today at 8:00am ET VANCOUVER, British Columbia and CAMBRIDGE, Mass. and BASEL, Switzerland, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company, and Arbutus Biopharma Corporation (Nasdaq: ABUS) today filed a lawsuit in the U...
Roivant Sciences Ltd. (ROIV) Q3 2022 Earnings Conference Call February 14, 2022 08:00 ET Company Participants Paul Davis - Head, Communications Matt Gline - Chief Executive Officer Richard Pulik - Chief Financial Officer Frank Torti - Vant Chair Eric Venker - President and Chief Operating Off...
The following slide deck was published by Roivant Sciences Ltd. in conjunction with their 2022 Q3 earnings call. For further details see: Roivant Sciences Ltd. 2022 Q3 - Results - Earnings Call Presentation
Roivant Sciences press release (NASDAQ:ROIV): Q4 GAAP EPS of -$0.41 misses by $0.17. Revenue of $24.34M (+323.3% Y/Y). For further details see: Roivant Sciences GAAP EPS of -$0.41 misses by $0.17, revenue of $24.34M
Roivant’s newly launched subsidiary, Hemavant, entered into a licensing agreement with Eisai Co., Ltd. for exclusive global rights to the investigational agent RVT-2001, a potential first-in-class small molecule modulator of splicing factor 3B subunit 1 (SF3B1) for the treatment of...
Gainers: Zillow Group (NASDAQ:Z) +20%. Zillow Group (NASDAQ:ZG) +18%. Enthusiast Gaming Holdings (NASDAQ:EGLX) +11%. Momentive Global (NASDAQ:MNTV) +8%. EMCORE Corporation (NASDAQ:EMKR) +7%. Losers: Confluent (NASDAQ:CFLT) -10%. Upwork (NASDAQ:U...
Quarterly investor call and webcast scheduled for Monday, February 14 at 8:00 a.m. ET Roivant will also present at the SVB Leerink Global Healthcare Conference in February, and the Truist AI Symposium and Cowen Healthcare Conference in March BASEL, Switzerland and LONDO...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-07-11 10:45:04 ET Rivian Automotive Inc (RIVN) RIVN is trading UP for the last 5 days, and it at trading at $16.74 with volume of 18,885,597 and a one day change of $0.37 (2.23%). Rivian Automotive Inc has a 52-week low of 12.15 and a 52-week high of $32.60. The business's 50-d...
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...